Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: A double-blind randomised placebo-controlled study
Diabetologia - Clinical and Experimental Diabetes and Metabolism | Jul 10, 2018
Bidirectional association between non-alcoholic fatty liver disease and hypertension from Dongfeng-Tongji cohort study
Journal of the American Society of Hypertension | Jul 07, 2018
Prevalence of suspected nonalcoholic fatty liver disease in lean adolescents in the United States
Journal of Pediatric Gastroenterology and Nutrition | Jul 01, 2018